SCOPUS 정보 검색 플랫폼

Volumn 19, Issue 31, 2001, Pages 4429-4433

A randomised comparison of two inactivated hepatitis A vaccines, Avaxim™ and Vaqta™, given as a booster to subjects primed with Avaxim™

(3) Clarke, Paul a Kitchin, Nicholas b Souverbie, Frédéric c

a MASTA (United Kingdom)

b Maidenhead Berkshire UK (United Kingdom)

c SANOFI PASTEUR (France)

Author keywords

Hepatitis A vaccine; Immunogenicity; Reactogenicity

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ASTHENIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INACTIVATION; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEADACHE; HEMATOMA; HEPATITIS A; HUMAN; INJECTION PAIN; MALAISE; MALE; MYALGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS ANTIBODIES; HEPATOVIRUS; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; RANDOM ALLOCATION; VACCINES, INACTIVATED;

EID: 0035860012 PISSN: 0264410X EISSN: None Source Type: Journal
DOI: 10.1016/S0264-410X(01)00195-5 Document Type: Conference Paper

Times cited : (17)

References (14)

1
- 0034602876
- Hepatitis A vaccines. WHO position paper
- (2000) Wkly Epidemiol Rec , vol.75 , Issue.5 , pp. 38-44

2
- 0026483413
- Risk of hepatitis A in travellers
- (1992) Vaccine , vol.10 , Issue.SUPPL. 1
- Steffen, R.¹

3
- 0026643021
- A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children
- (1992) N Engl J Med , vol.327 , pp. 453-457
- Werzberger, A.¹ Mensch, B.² Kuter, B.³

4
- 0028265277
- Protection against hepatitis A by an inactivated vaccine
- (1994) JAMA , vol.271 , pp. 28-34
- Innis, B.L.¹ Snitbhan, R.² Kunasol, P.³

5
- 0030449979
- Clinical development of a new inactivated hepatitis A vaccine
- (1996) Infection , vol.24 , Issue.6 , pp. 447-458
- Vidor, E.¹ Fritzell, B.² Plotkin, S.³

6
- 0028900520
- Vaqta™
- (1995) Drugs Future , vol.20 , Issue.1 , pp. 24-29
- Nalin, D.R.¹

7
- 0033991902
- Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines
- (2000) J Med Virol , vol.60 , Issue.1 , pp. 1-7
- Van Herck, K.¹ Beutels, P.² Van Damme, P.³

8
- 0031894298
- Immunogenicity and reactogenicity of Avaxim (160 AU) as compared with Havrix (1440 EL.U) as a booster following primary immunization with Havrix (1440 EL.U) against hepatitis A
- (1998) J Travel Med , vol.5 , pp. 18-22
- Zuckerman, J.N.¹ Kirkpatrick, C.T.² Huang, M.³

9
- 0034703805
- Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines
- (2001) Vaccine , vol.19 , pp. 743-750
- Bryan, J.P.¹ Henry, C.H.² Hoffman, A.G.³

10
- 0027378137
- Sensitive assays for hepatitis A antibodies
- (1993) J Med Virol , vol.41 , Issue.3 , pp. 201-204
- Miller, W.J.¹ Clark, W.² Hurni, W.³ Kuter, B.⁴ Schofield, T.⁵ Nalin, D.⁶

11
- 0029743994
- Duration of protection from clinical hepatitis A disease after vaccination with VAQTA
- (1996) J Med Virol , vol.49 , Issue.3 , pp. 235-241
- Wiens, B.L.¹ Bohidar, N.R.² Pigeon, J.G.³

12
- 0033597240
- Comparative immunogenicity and tolerance of Vaqta™ and Havrix™
- (1999) Vaccine , vol.17 , pp. 2181-2184
- Braconier, J.H.¹ Wennerholm, S.² Norrby, R.³

13
- 0030873293
- Comparison of the safety and immunogenicity of two inactivated hepatitis A vaccines
- (1997) Adv Therapy , vol.14 , Issue.3 , pp. 116-124
- Zuckerman, J.¹ Peyron, F.² Wallon, M.³

14
- 0029023611
- Immunogenicity and safety of a new inactivated hepatitis A vaccine in a comparative study
- (1995) J Med Virol , vol.46 , Issue.3 , pp. 287-292
- Goilav, C.¹ Zuckerman, J.² Lafrenz, M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.